PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

NCT03295695 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped closure of radiolaboratory

Conditions

Breast Cancer
Breast Cancer, Female
Breast Cancer, Male
Breast Neoplasms

Interventions

DIAGNOSTIC_TEST: Fluoro-D-glucose-positron Emission Tomography
BIOLOGICAL: 2-deoxy-2-[18F]fluoro-D-glucose (FDG)
DIAGNOSTIC_TEST: Echocardiogram

Sponsor

H. Lee Moffitt Cancer Center and Research Institute